Concentrx Pharmaceuticals, Inc.

Concentrx is developing The HALIX®️, Unit Dose Disposable Dry Powder Inhaler with world leading products for asthma and COPD.

  • Stage Product In Development
  • Industry Other
  • Location Durham, NC, US
  • Currency USD
  • Founded January 2010
  • Employees 5
  • Incorporation Type C-corp
  • Website concentrxpharma.com

Company Summary

Concentrx is developing world leading prescription pharmaceuticals for asthma and COPD in the HALIX unit dose disposable dry powder inhaler.
Unit dose is preferred in the hospital and emerging markets.
Currently all inhalers dispensed in the hospital are multi-dose.
We have an efficient and low cost inhaler. Product currently ready for clinical trials manufacturing in mid 2016. FDA approval is expected in 2018. Patent pending in 42 countries.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free